A University of New South Wales (UNSW) research project is tackling the rising global challenge of antibiotic resistance.
UNSW secured almost $5 million in Australian Research Council funding earlier this year to develop an integrated diagnostic and pharmaceutical approach to antibiotic resistance.
The project has been awarded funding over five years under the Australian Research Council (ARC) Industrial Transformation Research Program (ITRP) Hub grants which aim to engage Australia’s best researchers on issues facing industrial economies and training the future workforce.
Professor Rebecca Guy, an epidemiologist from the Kirby Institute and UNSW Medicine, will lead the hub to investigating antibiotic resistance.
It will be supported by a further $3.8 million in contributions from biotech company SpeeDx and other partners to develop a world-first partnership between industry, researchers and stakeholders to tackle antimicrobial resistance.
“We plan to develop new molecular diagnostic technology and improve the processes for identifying potential new antibiotics,” Professor Guy said.
“The hub aims to connect the many complex facets of antimicrobial resistance, to provide a highly integrated diagnostic and pharmaceutical solution to the problem.”
